218 related articles for article (PubMed ID: 29903912)
21. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
22. Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum.
Hansen G; Schuster A; Zubrod C; Wahn V
Respiration; 1995; 62(3):117-24. PubMed ID: 7569330
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.
Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA
Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923
[TBL] [Abstract][Full Text] [Related]
24. Thioredoxin and dihydrolipoic acid inhibit elastase activity in cystic fibrosis sputum.
Lee RL; Rancourt RC; del Val G; Pack K; Pardee C; Accurso FJ; White CW
Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L875-82. PubMed ID: 16214824
[TBL] [Abstract][Full Text] [Related]
25. Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.
Costello CM; O'Connor CM; Finlay GA; Shiels P; FitzGerald MX; Hayes JP
Thorax; 1996 Jun; 51(6):619-23. PubMed ID: 8693445
[TBL] [Abstract][Full Text] [Related]
26. Poly-L-Lysine compacts DNA, kills bacteria, and improves protease inhibition in cystic fibrosis sputum.
Dubois AV; Midoux P; Gras D; Si-Tahar M; Bréa D; Attucci S; Khelloufi MK; Ramphal R; Diot P; Gauthier F; Hervé V
Am J Respir Crit Care Med; 2013 Sep; 188(6):703-9. PubMed ID: 23947381
[TBL] [Abstract][Full Text] [Related]
27. Effects of cystic fibrosis airway secretions on rat lung: role of neutrophil elastase.
Rees DD; Brain JD
Am J Physiol; 1995 Aug; 269(2 Pt 1):L195-202. PubMed ID: 7653580
[TBL] [Abstract][Full Text] [Related]
28. DNase I acutely increases cystic fibrosis sputum elastase activity and its potential to induce lung hemorrhage in mice.
Cantin AM
Am J Respir Crit Care Med; 1998 Feb; 157(2):464-9. PubMed ID: 9476859
[TBL] [Abstract][Full Text] [Related]
29. Recombinant human Monocyte/Neutrophil elastase inhibitor protects rat lungs against injury from cystic fibrosis airway secretions.
Rees DD; Rogers RA; Cooley J; Mandle RJ; Kenney DM; Remold-O'Donnell E
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):69-78. PubMed ID: 9870919
[TBL] [Abstract][Full Text] [Related]
30. The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis.
Shah PL; Scott SF; Knight RA; Hodson ME
Eur Respir J; 1996 Mar; 9(3):531-4. PubMed ID: 8730015
[TBL] [Abstract][Full Text] [Related]
31. Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction.
Jackson PL; Xu X; Wilson L; Weathington NM; Clancy JP; Blalock JE; Gaggar A
Mol Med; 2010; 16(5-6):159-66. PubMed ID: 20111696
[TBL] [Abstract][Full Text] [Related]
32. Alpha-1 Antitrypsin-A Target for MicroRNA-Based Therapeutic Development for Cystic Fibrosis.
Hunt AMD; Glasgow AMA; Humphreys H; Greene CM
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012925
[TBL] [Abstract][Full Text] [Related]
33. Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis.
Broughton-Head VJ; Shur J; Carroll MP; Smith JR; Shute JK
Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1240-9. PubMed ID: 17827252
[TBL] [Abstract][Full Text] [Related]
34. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
[TBL] [Abstract][Full Text] [Related]
35. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
Rao NV; Argyle B; Xu X; Reynolds PR; Walenga JM; Prechel M; Prestwich GD; MacArthur RB; Walters BB; Hoidal JR; Kennedy TP
Am J Physiol Cell Physiol; 2010 Jul; 299(1):C97-110. PubMed ID: 20375277
[TBL] [Abstract][Full Text] [Related]
36. A specialized method of sputum collection and processing for therapeutic interventions in cystic fibrosis.
McElvaney OJ; Gunaratnam C; Reeves EP; McElvaney NG
J Cyst Fibros; 2019 Mar; 18(2):203-211. PubMed ID: 29960875
[TBL] [Abstract][Full Text] [Related]
37. Cytokine concentrations and neutrophil elastase activity in bronchoalveolar lavage and induced sputum from patients with cystic fibrosis, mild asthma and healthy volunteers.
McGarvey LP; Dunbar K; Martin SL; Brown V; Macmahon J; Ennis M; Elborn JS
J Cyst Fibros; 2002 Dec; 1(4):269-75. PubMed ID: 15463826
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory lung secretions inhibit dendritic cell maturation and function via neutrophil elastase.
Roghanian A; Drost EM; MacNee W; Howie SE; Sallenave JM
Am J Respir Crit Care Med; 2006 Dec; 174(11):1189-98. PubMed ID: 16959917
[TBL] [Abstract][Full Text] [Related]
39. alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis.
O'Connor CM; Gaffney K; Keane J; Southey A; Byrne N; O'Mahoney S; Fitzgerald MX
Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1665-70. PubMed ID: 8256917
[TBL] [Abstract][Full Text] [Related]
40. Proteases and antiproteases in cystic fibrosis: pathogenetic considerations and therapeutic strategies.
Birrer P
Respiration; 1995; 62 Suppl 1():25-8. PubMed ID: 7792437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
